Cargando…
In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
Biomarkers which better match anticancer drugs with cancer driver genes hold the promise of improved clinical responses and cure rates. We developed a precision medicine platform of rapid high‐throughput drug screening (HTS) and patient‐derived xenografting (PDX) of primary tumor tissue, and evaluat...
Ejemplares similares
-
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020) -
Molecular profiling of childhood cancer: Biomarkers and novel therapies
por: Saletta, Federica, et al.
Publicado: (2014) -
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018) -
DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020) -
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)